FRANK DANIEL — Molecular Insight Pharmaceuticals, Inc. insider: 14 transactions · InsiderLens

FRANK DANIEL — Molecular Insight Pharmaceuticals, Inc. insider: 14 transactions · InsiderLens

Société	Déclarée	Type	Qté	Prix	Valeur · USD	Src	Détail
Molecular Insight Pharmaceuticals, Inc.	May 17, 2010	AttributionD (dérivé)	-25,000	0.00	—	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 16, 2010	Autre	3,679	0.00	—	SEC
Molecular Insight Pharmaceuticals, Inc.	May 14, 2009	AttributionD (dérivé)	25,000	0.00	—	SEC
Molecular Insight Pharmaceuticals, Inc.	May 15, 2008	AttributionD (dérivé)	25,000	0.00	—	SEC
Molecular Insight Pharmaceuticals, Inc.	Nov 30, 2007	Exercice	4,167	4.80	$20K	SEC
Molecular Insight Pharmaceuticals, Inc.	Nov 30, 2007	ExerciceD (dérivé)	-4,167	0.00	—	SEC
Molecular Insight Pharmaceuticals, Inc.	Jun 28, 2007	AttributionD (dérivé)	25,000	0.00	—	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 5, 2007	Autre	12,626	—	—	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 5, 2007	AutreD (dérivé)	-12,626	3.96	$50K	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 5, 2007	AutreD (dérivé)	-1,894	—	—	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 5, 2007	Autre	72,120	—	—	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 5, 2007	AutreD (dérivé)	-1,488	—	—	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 5, 2007	Autre	54,367	—	—	SEC
I STAT CORPORATION /DE/	Feb 10, 2004	Autre	-96,200	15.35 USD	$1.5M	SEC